Mechanisms and Potential Therapeutic Targets
Francesco Lasorsa,Monica Rutigliano,Martina Milella,Antonio d'Amati,Felice Crocetto,Savio Domenico Pandolfo,Biagio Barone,Matteo Ferro,Marco Spilotros,Michele Battaglia,Pasquale Ditonno,Giuseppe Lucarelli
DOI: https://doi.org/10.3390/ijms25084332
IF: 5.6
2024-04-15
International Journal of Molecular Sciences
Abstract:Kidney transplantation offers a longer life expectancy and a better quality of life than dialysis to patients with end-stage kidney disease. Ischemia–reperfusion injury (IRI) is thought to be a cornerstone in delayed or reduced graft function and increases the risk of rejection by triggering the immunogenicity of the organ. IRI is an unavoidable event that happens when the blood supply is temporarily reduced and then restored to an organ. IRI is the result of several biological pathways, such as transcriptional reprogramming, apoptosis and necrosis, innate and adaptive immune responses, and endothelial dysfunction. Tubular cells mostly depend on fatty acid (FA) β-oxidation for energy production since more ATP molecules are yielded per substrate molecule than glucose oxidation. Upon ischemia–reperfusion damage, the innate and adaptive immune system activates to achieve tissue clearance and repair. Several cells, cytokines, enzymes, receptors, and ligands are known to take part in these events. The complement cascade might start even before organ procurement in deceased donors. However, additional experimental and clinical data are required to better understand the pathogenic events that take place during this complex process.
biochemistry & molecular biology,chemistry, multidisciplinary